Yin Wu, Clinical Lecturer TCT Lab, UCL Cancer Institute Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Early Careers Network Session Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.

894

6/6/2019

Alexandra Lubin, Dept of Haematology, UCL Cancer Institute Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Early Careers Network Session Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.

635

6/6/2019

Professor Alison Lloyd Professor Andrew Pomiankowski Professor Charles Swanton Dr Duncan Greig Professor David Gems Professor Tariq Enver Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Cancer evolution: can we beat Nature? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.

701

6/3/2019

Prof Tariq Enver Professor of Stem Cell Biology Director, Cancer Institute Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Cancer evolution: can we beat Nature? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.

150

6/3/2019

Prof Charles Swanton UCL Cancer Institute & The Francis Crick Institute Director, CRUK UCL Lung Cancer Centre Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Cancer evolution: can we beat Nature? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.

684

6/3/2019